Evaluation of NK1 Antagonist in Post-Traumatic Stress

ID Number 04-0900

Principal Investigator(s)
Dan V. Iosifescu

Department(s) or Division(s)
Psychiatry

Description

The purpose of this study is to test the safety and effectiveness of an experimental drug for PTSD, GSK561679, compared to a placebo, which is a pill with no active substance. Patients may qualify for participation in this study if they have a diagnosis of PTSD, and have current symptoms of the disorder.



Contact Information
Solara Calderon
(212) 241-7910
solara.calderon@mssm.edu


Recruiting Patients: Yes